Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 6, 2003. The report primarily details corporate actions regarding share re-purchases and updates on directors' interests in company shares.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. Specific transaction data includes:
- Share Re-purchase: 800,000 Ordinary 25 pence shares purchased for cancellation on October 29, 2002, at 1,235.88 pence per share.
- US Retirement Savings Plan (ADR) Holdings:
- January 2, 2003: Decreased from 18,343,751 to 18,290,955 ADRs at an average price of $38.51.
- January 3, 2003: Increased from 18,290,955 to 18,320,180 ADRs at an average price of $38.83.
- Director Share Acquisition: Director J.D. Coombe acquired 2 Ordinary Shares on January 3, 2003, at £11.94 per share via the ShareReward Plan.
Material Changes
The filing reports specific changes in equity structure and director holdings rather than operational performance changes:
- Reduction in outstanding share count due to the cancellation of 800,000 shares.
- Fluctuations in the number of ADRs held by the US Retirement Savings Plan, affecting the indirect interests of Directors Dr. J.P. Garnier and Mr. J.D. Coombe.
- Direct acquisition of shares by Director J.D. Coombe through the Dividend Reinvestment element of the ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is strictly a notification of regulatory compliance regarding share transactions and director interests.
Key Facts for Investor Verification
- Verify the total number of shares outstanding following the cancellation of 800,000 shares on October 29, 2002.
- Confirm the aggregate value of the share re-purchase program utilized under the authority granted at the May 20, 2002 Annual General Meeting.
- Review the full extent of directors' interests in the US Retirement Savings Plan to understand potential conflicts or alignment with employee beneficiaries.
- Check subsequent filings for the impact of these share movements on earnings per share (EPS) calculations.